A postdoctoral H2020 funded position is available, to develop a deeper understanding of the relevance of in vivo Drosophila models to study pathologies of disease, within Acies Bio – a research driven biotech company based in Slovenia.
We welcome applicants who hold a PhD in a relevant subject, or are nearing completion. A successful candidate would be an independent researcher, experienced in disease model development: particularly in vivo models in the fruit fly Drosophila melanogaster. Expertise in molecular biology model development, phenotypic characterisation, and candidate compound efficacy evaluation is desirable. The Innovation Associate will be responsible for developing and implementing phenotypic assays on existing disease models as well as generating new models for disease.
The researcher will have access to state-of-the-art facilities and work in an international and interdisciplinary setting. The candidate can expect to maintain an active international research profile through publications, academic partnerships and attendance at conferences (including the EDRC 2017). They will also gain insight into commercial aspects of drug discovery research programmes and receive mentorship in the area of intellectual property protection and IP-driven experimental design strategies. This 1 year fixed post will commence on 01/09/17, however there would be a strong, realistic desire towards continuing employment.
This position must comply with MSCA mobility criteria (<12 months work in Slovenia since Sept 2014), and relocation expenses would be covered. The Associate will have the benefit of working in a lively European capital (integration fully supported with afternoon language lessons), and living in an ideally located Central European country with access to the Mediterranean, the Julian Alps, and 4 neighbouring countries. Slovenia has an MSCA country correction coefficient of 86% – reflecting the low cost of living.
For further information and to submit an application for this vacancy visit